Brominated Flame Retardants vs Acesulfame Potassium: which is worse?

What is Brominated Flame Retardants?

Brominated flame retardants (BFRs) are a class of synthetic chemicals added to consumer products and materials to reduce flammability. They include polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD), and others. While not direct food additives, they contaminate the food supply through environmental pathways and food packaging.

What is Acesulfame Potassium?

Acesulfame potassium (Ace-K) is a calorie-free synthetic sweetener approximately 200 times sweeter than sucrose. It contains a potassium atom bonded to an oxathiazinone dioxide ring structure. It is heat-stable and non-metabolized, passing through the body unchanged. Often blended with sucralose or aspartame to mask bitter aftertaste.

Documented risks

Brominated Flame Retardants: PBDEs and other BFRs are endocrine disruptors, neurodevelopmental toxicants, and probable carcinogens. They accumulate in human adipose tissue, breast milk, and blood. PBDEs were found in 100% of samples in multiple US population biomonitoring studies. US women have PBDE body burdens 10-100 times higher than European women, reflecting the US's historically heavy PBDE use before bans. Neurodevelopmental effects: multiple studies have associated prenatal PBDE exposure with lower IQ, attention deficits, and behavioral problems in children. A 2012 Environmental Health Perspectives study found inverse associations between PBDE cord blood levels and child IQ and behavioral outcomes. Thyroid disruption: BFRs structurally mimic thyroid hormones and compete with thyroid hormone binding proteins, disrupting the thyroid axis — critical for fetal brain development. Carcinogenicity: some PBDEs are associated with thyroid cancer risk in human studies. PBDEs enter the food supply primarily through fatty fish (salmon, tuna), meat, dairy, and some contaminated produce from biosolid-amended soils.

Acesulfame Potassium: The safety database for Ace-K is considered less comprehensive than that for other sweeteners. Critics have argued that the original FDA approval studies from the 1970s-1980s were insufficient in quality and length to definitively establish long-term safety. The Center for Science in the Public Interest (CSPI) has petitioned for additional testing. Two rat studies found statistically significant increases in lung tumors (in male rats) and mammary tumors at high doses. Regulatory agencies have argued these doses far exceeded typical human exposure and attributed the tumor findings to other factors. However, the question of whether Ace-K's approval studies meet modern standards has been raised by independent researchers. A 2021 study in Cell found that Ace-K and other non-nutritive sweeteners altered gut microbiome composition and affected glucose tolerance in some human participants. Ace-K specifically was associated with changes in gut bacteria that correlated with glycemic effects. Neurological concerns: some animal studies suggest Ace-K may affect brain neurotransmitter systems. A 2013 study in PLoS ONE found that Ace-K consumption in pregnant mice altered offspring postnatal taste preference and increased weight gain, suggesting potential transgenerational effects. These findings were at doses exceeding typical human intake. Endocrine disruption potential has been raised in some in vitro studies, but comprehensive human data are lacking.